Flucelvax
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
83703-088 -
Package NDC
83703-088-03 -
Application number
BLA125408 -
SPL ID
547566e6-e167-be56-e063-6294a90af9f9
What the source publishes
- Labeler
- Bamboo US BidCo LLC
- Active ingredients
- INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- Form
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- VACCINE
Names this record is found by
- Flucelvax
- INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/VICTORIA/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
Complete source data
{
"name": "Flucelvax",
"splId": "547566e6-e167-be56-e063-6294a90af9f9",
"labels": [],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "Bamboo US BidCo LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 SYRINGE, GLASS in 1 CARTON (83703-088-03) / .5 mL in 1 SYRINGE, GLASS (83703-088-04)",
"package_ndc": "83703-088-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20260801"
}
],
"productId": "83703-088_547566e6-e167-be56-e063-6294a90af9f9",
"useDomain": "unknown",
"dosageForm": "INJECTION, SUSPENSION",
"productNdc": "83703-088",
"deaSchedule": null,
"genericName": "INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)",
"productType": "VACCINE",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)",
"strength": "15 ug/.5mL"
},
{
"name": "INFLUENZA A VIRUS A/VICTORIA/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)",
"strength": "15 ug/.5mL"
},
{
"name": "INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)",
"strength": "15 ug/.5mL"
}
],
"applicationNumber": "BLA125408",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260801",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:83703-088_547566e6-e167-be56-e063-6294a90af9f9"